Rocuronium Bromide



Indications and Reactions:

Role Indications Reactions
Primary
Induction Of Anaesthesia 17.8%
Product Used For Unknown Indication 16.1%
Anaesthesia 13.0%
Neuromuscular Blocking Therapy 10.2%
General Anaesthesia 9.5%
Anaesthesia Procedure 5.1%
Maintenance Of Anaesthesia 5.1%
Muscle Relaxant Therapy 4.4%
Surgery 2.8%
Hypotonia 2.5%
Endotracheal Intubation 2.4%
Neuromuscular Blockade 2.2%
Drug Use For Unknown Indication 2.1%
Induction And Maintenance Of Anaesthesia 1.6%
Sedation 1.2%
Neuromuscular Blockade Reversal 1.1%
Anaesthetic Premedication 0.8%
Antibiotic Prophylaxis 0.8%
Prophylaxis 0.7%
Analgesic Therapy 0.6%
Drug Ineffective 11.3%
Tachycardia 9.7%
Neuromuscular Block Prolonged 9.2%
Cardiac Arrest 8.8%
Urticaria 7.6%
Drug Effect Decreased 6.7%
Rhabdomyolysis 5.5%
Anaphylactic Reaction 4.6%
Product Quality Issue 4.2%
Respiratory Arrest 3.8%
Circulatory Collapse 3.4%
Delayed Recovery From Anaesthesia 3.4%
Ventricular Tachycardia 3.4%
Dyspnoea 2.9%
Hypotension 2.9%
Procedural Complication 2.9%
Pulmonary Oedema 2.5%
Therapeutic Response Decreased 2.5%
Tongue Oedema 2.5%
Drug Effect Prolonged 2.1%
Secondary
Product Used For Unknown Indication 24.7%
Drug Use For Unknown Indication 15.6%
Anaesthesia 11.5%
General Anaesthesia 9.2%
Induction Of Anaesthesia 8.0%
Maintenance Of Anaesthesia 5.7%
Ill-defined Disorder 5.2%
Anaesthesia Procedure 2.5%
Infection 2.2%
Constipation 2.0%
Sedation 2.0%
Pyrexia 1.9%
Hypotonia 1.5%
Prophylaxis 1.5%
Induction And Maintenance Of Anaesthesia 1.3%
Endotracheal Intubation 1.1%
Preoperative Care 1.1%
Muscle Relaxant Therapy 1.0%
Pain 1.0%
Neuromuscular Blockade Reversal 1.0%
Drug Rash With Eosinophilia And Systemic Symptoms 13.9%
Anaphylactic Shock 10.3%
Rhabdomyolysis 8.5%
Tachycardia 8.5%
Anaphylactic Reaction 7.2%
Hypotension 7.2%
White Blood Cell Count Increased 4.9%
Stevens-johnson Syndrome 4.5%
Pulmonary Oedema 4.0%
Serotonin Syndrome 3.6%
Toxic Skin Eruption 3.6%
Ventricular Tachycardia 3.6%
Drug Interaction 3.1%
Drug Ineffective 2.7%
Endotracheal Intubation Complication 2.7%
Unresponsive To Stimuli 2.7%
Cardiac Arrest 2.2%
Drug Effect Decreased 2.2%
Drug Effect Increased 2.2%
Drug Exposure During Pregnancy 2.2%
Concomitant
Product Used For Unknown Indication 16.9%
Anaesthesia 13.2%
Induction Of Anaesthesia 11.6%
General Anaesthesia 9.6%
Drug Use For Unknown Indication 9.1%
Maintenance Of Anaesthesia 8.4%
Prophylaxis 5.7%
Analgesic Therapy 3.7%
Surgery 2.9%
Induction And Maintenance Of Anaesthesia 2.5%
Pain 2.1%
Hypertension 2.1%
Anaesthesia Procedure 1.7%
Hypotonia 1.6%
Infection Prophylaxis 1.6%
Sedation 1.6%
Premedication 1.5%
Supportive Care 1.5%
Prophylaxis Of Nausea And Vomiting 1.3%
Sedative Therapy 1.3%
Ventricular Tachycardia 10.3%
Serotonin Syndrome 8.5%
Vomiting 8.1%
Rhabdomyolysis 6.6%
Cardiac Arrest 6.3%
Ventricular Fibrillation 5.9%
Bradycardia 5.1%
Pain 4.8%
Anaphylactic Shock 4.4%
Hyperthermia Malignant 4.4%
Hypotension 4.0%
Stress Cardiomyopathy 4.0%
Unevaluable Event 4.0%
Injury 3.7%
Pyrexia 3.7%
Drug Interaction 3.3%
Tachycardia 3.3%
Unresponsive To Stimuli 3.3%
White Blood Cell Count Increased 3.3%
Anaphylactic Reaction 2.9%
Interacting
General Anaesthesia 25.0%
Breast Cancer 8.3%
Dementia Alzheimer's Type 8.3%
Prophylaxis Of Nausea And Vomiting 8.3%
Thyroglossal Cyst Excision 8.3%
Anaesthesia 5.6%
Arrhythmia 5.6%
Atrial Fibrillation 5.6%
Induction And Maintenance Of Anaesthesia 5.6%
Arrhythmia Prophylaxis 2.8%
Hypertension 2.8%
Induction Of Anaesthesia 2.8%
Maintenance Of Anaesthesia 2.8%
Muscle Relaxant Therapy 2.8%
Osteomyelitis 2.8%
Product Used For Unknown Indication 2.8%
Neuromuscular Block Prolonged 43.8%
Drug Interaction 18.8%
Drug Effect Decreased 6.3%
Extrasystoles 6.3%
Hypotension 6.3%
Potentiating Drug Interaction 6.3%
Ventricular Fibrillation 6.3%
Ventricular Tachycardia 6.3%